Foundayo Reviews 2026: Honest Verdict, Real Cost, and Who Should Actually Use It

By WPG Research Team · Last verified: April 11, 2026 · Pricing checked on Ro, LillyDirect, Weight Watchers, and GoodRx

Last updated: April 11, 2026. Foundayo launched April 9, 2026. We will update pricing and real-world review data monthly. How we rank and vet providers.

Foundayo (orforglipron) — once-daily GLP-1 pill. Take it with or without food, no needles, swallow tablet whole. Foundayo bottle pictured beside a healthy breakfast, glass of water, and coffee on a kitchen counter.

Our Verdict — April 11, 2026

Foundayo (orforglipron) is legitimate, FDA-approved, and the easiest oral GLP-1 to live with day to day. For needle-averse adults who want a daily GLP-1 pill without fasting rules or water restrictions, Foundayo is currently the most convenient oral option available. In the ATTAIN-1 clinical trial, adults on the highest approved dose lost an average of 25 pounds (11.1% body weight) over 72 weeks.

The catch most reviews won't tell you: the real cost escalates with each dose increase. Month 1 is $149. Month 2 jumps to $199. Month 3 hits $299. Your 90-day medication total is $647 — before any platform or membership fees.

Best forNeedle-averse adults, busy mornings, travelers, first-time GLP-1 users
Not best forPeople succeeding on an injectable, or chasing maximum weight loss %
Medication cost$149–$299/mo self-pay by dose
90-day medication total$647 (medication only, no platform fee)
Easiest start routeRo — start for $39, insurance concierge included
Lowest all-in cash routeLillyDirect — $0 platform fee with existing Rx
Check Foundayo eligibility on Ro →Already have an Rx? See LillyDirect pricing →

Are Foundayo Reviews Even Trustworthy Yet?

Foundayo was FDA-approved on April 1, 2026, and became broadly available on April 9, 2026. That means the drug has been in real patients' hands for days, not months. Anyone claiming to have extensive “real user reviews” right now is working from a very thin evidence base.

A credible Foundayo review at this point is an evidence stack built from the official prescribing information, Phase 3 clinical trial results (ATTAIN-1 and ATTAIN-2, enrolling over 4,500 participants combined), verified pricing across access routes, clinician commentary from published sources, and the earliest real community reactions. That is exactly what this page is.

What we verified directly, April 11, 2026:

  • FDA approval status and prescribing information — confirmed via FDA.gov and Lilly investor relations, April 1, 2026
  • Ro pricing and membership terms — verified on Ro.co/weight-loss/foundayo and Ro.co/weight-loss/pricing, April 11, 2026
  • LillyDirect dose-by-dose pricing and 45-day refill rule — verified on LillyDirect Foundayo page, April 11, 2026
  • Weight Watchers Med+ terms — verified on WeightWatchers.com/foundayo, April 11, 2026
  • GoodRx access path — verified on GoodRx Foundayo care page, April 11, 2026
  • Clinical trial data — ATTAIN-1 (NCT05869903) and ATTAIN-2 (NCT05872620) per Lilly published data

Our Honest Verdict: Who Should Actually Use Foundayo

Foundayo is strongest for people who value sticking with treatment more than chasing the absolute highest published weight-loss number. That is not a weakness — it is a practical insight that most clinical reviews miss entirely. GLP-1 medications only work when people actually take them consistently. A significant portion of patients discontinue within the first year — often because of injection anxiety, complex dosing routines, or lifestyle friction. Foundayo eliminates all three of those barriers in one pill.

Foundayo is the strongest fit if you are:

  • Needle-averse. You've thought about Ozempic or Wegovy but the injection has always been a dealbreaker. Foundayo is a once-daily pill — no needles, no refrigeration, no injection-site reactions.
  • Too busy for fasting routines. Oral Wegovy must be taken first thing on an empty stomach with only a sip of water, then a 30-minute wait before eating anything. Foundayo has zero food or water restrictions — take it whenever works for you.
  • A first-time GLP-1 user. A pill you take with breakfast feels less clinical than a weekly injection, and that psychological barrier matters more than most people admit.
  • A frequent traveler or shift worker. One early Foundayo user told Business Insider they travel often and found the pill “very simple to add” to their routine — no cold storage, no sharps disposal, no scheduling injections around flights.

Foundayo is probably NOT right if you:

  • Are already succeeding on Zepbound or injectable Wegovy. If your current GLP-1 is working and the injection doesn't bother you, switching means accepting a lower weight-loss ceiling for convenience you may not need.
  • Want the maximum possible weight-loss percentage. Zepbound (tirzepatide) has demonstrated ~20%+ weight loss in clinical trials. Foundayo's highest published result is 12.4% on the top dose. If the biggest number is your priority, an injectable dual-agonist is the stronger tool.
  • Have a relevant contraindication. Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2) is a hard contraindication. Discuss your full medical history with your prescriber.
Foundayo travel advantages: once-daily tablet, room-temperature storage, no needles, take with or without food. Foundayo bottle shown at an airport alongside a travel routine kit, passport, and sunglasses.

The one thing we would change about Foundayo

Foundayo does NOT deliver the top-end weight loss seen with Zepbound. If maximum pounds lost is your single highest priority, Zepbound remains the stronger benchmark — its dual-agonist mechanism produces meaningfully more weight loss in clinical data. But Foundayo skips injections and the morning-fasting routine entirely, which means it may be the medication people actually take every single day. The best GLP-1 isn't the one with the highest trial number — it's the one you'll stick with at month 6 and month 12. Ro carries Zepbound too — your provider can help you decide.

Check Foundayo eligibility on Ro — starts at $39 →

How Much Weight Do People Actually Lose on Foundayo?

In the 72-week ATTAIN-1 clinical trial, adults without diabetes who took Foundayo's highest approved dose (17.2 mg tablet, equivalent to the 36 mg research capsule) lost an average of 25 pounds — approximately 11.1% of their starting body weight of 227 pounds. Among those who stayed on treatment through the full 72 weeks, weight loss reached 27.3 pounds (12.4%).

Those are clinically meaningful numbers. But context matters — here is how weight loss breaks down across every approved dose:

Foundayo Weight Loss by Dose (ATTAIN-1 Trial, 72 Weeks, Adults Without Diabetes)

Approved DoseAvg. Weight Loss %Avg. Lbs Lost
5.5 mg7.4%~17 lbs
9 mg8.3%~19 lbs
17.2 mg (max)Max dose11.1%~25 lbs
Placebo2.1%~5 lbs

Source: Eli Lilly ATTAIN-1 trial (NCT05869903); treatment regimen analysis (intent-to-treat). Foundayo.lilly.com. For adults with type 2 diabetes (ATTAIN-2, 1,600+ participants): 5.1% at 5.5 mg, 7.0% at 9 mg, 9.6% at 17.2 mg.

When to expect results: Most people begin to see some effect within the first 4 weeks, but meaningful weight loss takes 3–6 months because the dose titrates up gradually. You start at 0.8 mg for the first month, then step up monthly. The slow titration keeps GI side effects manageable. One important nuance: 35.9% of participants on the highest dose lost 15% or more of their body weight. That means the majority lost between 5% and 15%. Averages are averages — your result depends on starting weight, dose tolerance, dietary changes, and activity.
Foundayo dose path titration schedule: start at 0.8 mg once daily, increase to 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and maximum 17.2 mg. Doses increase based on response and tolerability. Swallow tablets whole.

Foundayo Cost: What You Will Really Pay in Month 1, Month 3, and Beyond

This is where most pages miss the real question. Foundayo's medication price starts at $149/month, but it does not stay there. The dose escalates monthly, and the price climbs with it.

Foundayo Medication Price by Dose (Self-Pay via LillyDirect / Ro)

DoseMonthly Med Cost
0.8 mg$149/mo
2.5 mg$199/mo
5.5 mg$299/mo
9 mg$299/mo
14.5 mg$299/mo
17.2 mg (max)$299/mo

Source: LillyDirect Foundayo pricing page and Ro Foundayo page, both verified April 11, 2026.

The First 90 Days: Real Math, Not Marketing

Most “starting at $149” messaging gives you the month-1 number and stops there. Here is what you will actually spend on medication alone during the standard 3-month titration:

$149+$199+$299=$647

medication only, before any platform or membership fees

Foundayo 90-Day Real Start Cost by Access Route

Route90-Day Total
LillyDirect$647
GoodRx Care$764
Weight Watchers Med+$820
Ro$984

Sources: LillyDirect, Ro pricing, WW Foundayo page, GoodRx Foundayo care, all verified April 11, 2026. Ro's annual prepay plan reduces membership to as low as $74/month, which would bring the 90-day total closer to $795 — but requires paying the full year upfront. A clinician may hold a dose longer, which could change the medication total.

The 45-Day Refill Rule Most Sites Don't Mention

At the 14.5 mg and 17.2 mg doses, Eli Lilly's Self-Pay Journey Program offers a discounted price of $299/month — but only if you complete your next refill within 45 days of your last delivery. Miss that window and the price reverts to the standard $349/month — a $50/month penalty for a late refill. Set a calendar reminder. This matters.
What “As Low as $25/Month With Insurance” Actually Means: If you have commercial health insurance that covers Foundayo, Eli Lilly offers a free Foundayo Savings Card that can bring your copay down to as low as $25 per month. Governmental beneficiaries (Medicare, Medicaid, Tricare) are excluded from the savings card by federal law. For Medicare Part D beneficiaries, Eli Lilly has stated that eligible patients may be able to access Foundayo for approximately $50 per month beginning as soon as July 1, 2026.
Check Foundayo pricing + insurance on Ro →See Lilly Savings Card details →

Ro vs. LillyDirect vs. Weight Watchers vs. GoodRx: Which Foundayo Route Is Smartest?

There is no single best route for everyone — but there is a best route for your situation. It comes down to one question: do you already have a prescriber, or are you starting from scratch?

Starting from zero and want the easiest path

→ Ro

Best for this situation

Ro announced Foundayo availability on April 9, 2026 — the same day Lilly expanded to retail pharmacies. Ro is the strongest starting point for most first-time Foundayo users because it combines everything into one workflow:

  1. 1.Complete an online health assessment (~5 minutes)
  2. 2.A licensed provider reviews your information and prescribes Foundayo if clinically appropriate
  3. 3.Ro checks your insurance coverage and handles prior authorization paperwork if needed
  4. 4.Medication ships to your door (or pickup at a retail pharmacy if using insurance)
  5. 5.Ongoing provider check-ins and 24/7 care team access

The membership costs $39 for the first month, then $149/month month-to-month — or as low as $74/month if you prepay annually. That fee covers your provider, insurance concierge, care team messaging, and ongoing monitoring. It is separate from the medication cost.

Why Ro specifically: Ro carries the most comprehensive GLP-1 formulary of any telehealth company — including Foundayo, oral Wegovy, injectable Wegovy, and Zepbound. If you start on Foundayo and your provider thinks you would respond better to a different medication, or if insurance covers one but not the other, they can pivot without you starting over on a new platform.

Get started with Foundayo on Ro →

Already have a prescription

→ LillyDirect

Best for this situation

LillyDirect is Eli Lilly's direct-to-patient pharmacy service. If your doctor has already written a Foundayo prescription, LillyDirect is the lowest-cost path — no added membership fee. Your doctor sends the prescription to LillyDirect Pharmacy (NPI: 1912889320), and Lilly handles fulfillment with free home delivery or retail pharmacy pickup through Walmart and other partners. LillyDirect automatically checks your insurance coverage and applies the Foundayo Savings Card if eligible.

The tradeoff: LillyDirect does not include a prescriber. If you do not already have a doctor willing to prescribe Foundayo, you will need to find one separately. That is when Ro adds value.

See LillyDirect Foundayo pricing →

Want coaching and community

→ Weight Watchers Med+

Best for this situation

Weight Watchers launched Foundayo access through their Med+ program, bundling medication with behavioral coaching and their GLP-1 Success nutrition program. Membership starts at $25 for the first month with a 12-month commitment, then $74/month.

Two things to know before choosing WW: First, the 12-month commitment is binding — not month-to-month. Second, WW has stated they cannot check insurance coverage for Foundayo at this time. That means you are on the self-pay path if you go through WW, at least initially. If you just want medication and clinical oversight, Ro or LillyDirect is leaner.

Want budget prescriber access

→ GoodRx Care

Best for this situation

GoodRx has added Foundayo to their Care platform, offering prescriber access for $39/month for unlimited online care. Your 90-day total via GoodRx Care is approximately $764 — more than LillyDirect but less than Ro month-to-month. GoodRx is a newer Foundayo pathway; verify current terms before enrolling, as their Foundayo access flow is still being established.

Foundayo vs. Oral Wegovy vs. Zepbound: Which GLP-1 Is Actually Better?

The honest answer is: it depends on what you value most. Convenience, efficacy, and cost all point to different choices. Here is the full comparison.

Daily routine comparison between Foundayo and Oral Wegovy. Foundayo: daily pill, with or without food, any time of day, no water restrictions. Oral Wegovy: daily pill, empty stomach in the morning, water only up to 4 ounces, wait at least 30 minutes before food drinks or other oral medications. Both are oral GLP-1 options for weight management.
FactorFoundayo (orforglipron)Oral Wegovy (sema)Zepbound injectable (tirz)
FormatDaily pillDaily pillWeekly injection
Food/water restrictionsNone — any time, with or without foodEmpty stomach, sip of water, 30-min waitNone
Needle requiredNoNoYes
RefrigerationNo (room temp, protect from light)No (room temp)Yes (until first use)
MechanismGLP-1 agonist (single)GLP-1 agonist (single)GLP-1 + GIP agonist (dual)
Avg. weight loss (highest dose)~12.4% / ~27 lbs (on-treatment)~16.6% (cross-trial; not head-to-head)~20%+ (cross-trial)
Self-pay starting price$149/mo (0.8 mg)$149/mo$299/mo (2.5 mg via Ro, membership separate)
FDA cardiovascular benefitNot yet approvedYes (reduces CV risk)Not yet for weight indication
Oral contraceptive interactionYes — alternative needed during titrationCheck prescribing infoCheck prescribing info
Simvastatin restrictionDo not exceed 20 mg/day (CYP3A4)No specific restrictionNo specific restriction
ManufacturerEli LillyNovo NordiskEli Lilly
Available via RoYesYesYes

Sources: Eli Lilly prescribing information (Foundayo PI); Novo Nordisk Wegovy PI; FDA approval announcements. Weight-loss percentages are from separate clinical trials and cannot be directly compared — no head-to-head trial exists.

Convenience Winner: Foundayo

Foundayo wins on daily livability. Take it whenever you want, with whatever you want. Oral Wegovy requires waking up, taking the pill on a completely empty stomach with only a small sip of plain water, then waiting a full 30 minutes before eating, drinking anything else, or taking other medications. For shift workers, parents of young kids, or anyone with an unpredictable morning routine, that is a real burden. A physician quoted in Managed Healthcare Executive noted that a daily pill with no restrictions may drive better long-term adherence than a pill with a strict fasting protocol, even if the fasting pill shows higher peak weight loss in a controlled trial.

Potency Winner: Zepbound

If maximum weight loss is your primary goal and you are comfortable with a weekly injection, Zepbound (tirzepatide) is the most powerful GLP-1 medication currently available for weight management. Its dual-agonist mechanism (targeting both GLP-1 and GIP receptors) produces significantly more weight loss than any single-agonist medication. Ro carries Zepbound alongside Foundayo and Wegovy — your provider can help determine whether the higher efficacy ceiling outweighs the convenience of a daily pill.

Oral Weight-Loss Signal: Oral Wegovy Leads — With a Major Caveat

In cross-trial comparisons, oral Wegovy shows approximately 16.6% weight loss at its highest dose compared to Foundayo's approximately 12.4% (on-treatment). That gap appears meaningful. But these numbers come from different clinical trials with different patient populations, protocols, and endpoints. No head-to-head study exists. Managed Healthcare Executive explicitly cautioned that comparing results across OASIS 4 (oral Wegovy) and ATTAIN-1 (Foundayo) carries inherent limitations. If you can stick to the morning-fasting protocol, oral Wegovy may deliver more weight loss on average. If you cannot or will not — Foundayo's advantage is real.

Who should choose what:

Needle-averse, busy morning routine, traveler, first-time user→ FoundayoMost convenient daily routine; no fasting; no injections
Motivated to follow fasting routine, wants higher weight-loss ceiling among pills→ Oral WegovyHigher cross-trial weight-loss data; established cardiovascular benefit
Open to injections, wants maximum efficacy→ Zepbound injectableHighest published weight-loss numbers; dual-agonist mechanism
On commercial insurance that covers Wegovy or Zepbound→ Ro for insurance navigationPrior auth support + most comprehensive formulary

Foundayo Side Effects: What Actually Matters Before You Start

The most common side effects are gastrointestinal: nausea, constipation, diarrhea, vomiting, abdominal pain, heartburn, gas, bloating, and indigestion. These are reported in 5% or more of patients in clinical trials and are consistent with the broader GLP-1 medication class. Most GI side effects are worst during the dose titration phase (the first 2–3 months) and tend to improve as your body adjusts. The titration schedule — starting at 0.8 mg and stepping up every 30 days — is specifically designed to minimize these effects.

CategorySide Effects
Common (usually manageable)Nausea, constipation, diarrhea, abdominal pain, heartburn, gas, bloating, indigestion, belching
NotableHair loss, headache, tiredness, vomiting
Serious (rare)Pancreatitis, gallbladder problems, kidney injury from dehydration, severe allergic reactions
Boxed warningThyroid C-cell tumors

Source: Foundayo prescribing information (pi.lilly.com/us/foundayo-uspi.pdf); FDA approval announcement, April 1, 2026.

The Birth Control Warning Most Foundayo Reviews Skip

Foundayo may reduce the effectiveness of oral birth control pills. The prescribing information states you should switch to a non-oral contraceptive method or add a barrier method for 30 days after starting Foundayo and for 30 days after each dose increase. Given that the standard titration involves multiple dose increases over the first several months, this effectively means women on oral contraceptives should plan for alternative birth control throughout the entire titration period. This is not a dealbreaker — it is a planning item. But you need to know about it before your first pill, not after.

The Simvastatin Cap: A Specific Number, Not a Vague Warning

Foundayo is metabolized by the CYP3A4 enzyme pathway. The most clinically relevant interaction for the typical Foundayo user: if you take simvastatin, do not exceed simvastatin 20 mg once daily while on Foundayo. That is a specific label instruction, not a generic “talk to your doctor.” If you are currently on a higher simvastatin dose, your prescriber will need to adjust it or switch you to a different statin before starting Foundayo. This is one reason starting through Ro — where a licensed provider reviews your full medication list before prescribing — reduces the risk of a drug interaction falling through the cracks.

Additional label precautions worth knowing:

  • Gastroparesis: Foundayo is not recommended for people with severe gastroparesis (severely delayed stomach emptying).
  • Surgery / anesthesia: Tell your care team you are taking Foundayo before any procedure using general anesthesia or deep sedation — food may remain in your stomach longer than expected.
  • Other GLP-1 medications: Concomitant use with another GLP-1 receptor agonist is not recommended. Work with your provider on transition timing if switching.
  • Pregnancy and breastfeeding: Foundayo may harm an unborn baby and is not recommended during pregnancy or breastfeeding. Discuss family planning with your provider before starting.
Have questions about drug interactions? A licensed Ro provider reviews your full health profile before prescribing →

What Early Foundayo Users and Doctors Are Actually Saying

The real-world review base for Foundayo is thin — the drug has been in patients' hands for days, not months. But the early signals from clinicians, published interviews, and community reactions point in a consistent direction.

What patients are saying

“Very simple to add to my daily routine.”

— Frequent business traveler, Business Insider, April 2026

“No strict routine like the Wegovy pill.”

— r/RoBody community, April 2026

“You do not need to pay a $150/month membership!”

— r/FoundayoUS user (noting LillyDirect option), April 2026

What doctors are saying

“Foundayo helps normalize obesity treatment — people are used to taking a pill for blood pressure or cholesterol.”

— Dr. Tara Narula, ABC News Chief Medical Correspondent, Good Morning America, April 2026

“The drug addresses both the clinical realities of obesity and the practical challenges patients face every day.”

— Dr. Deborah Horn, Center for Obesity Medicine, UTHealth Houston, Lilly FDA Announcement, April 2026

What these early reactions prove — and don't prove: They show that Foundayo's convenience positioning is landing with real patients and clinicians. They show that needle-averse adults are excited to have an option. They do NOT represent long-term efficacy in real-world settings, and they cannot predict how insurance coverage will evolve. We will update this section monthly as real-world data and genuine patient reviews accumulate.

How to Get Foundayo Online Safely

Foundayo is available right now through multiple legitimate channels. Here is exactly how to get started through the fastest path for most people.

The fastest path for most people: Ro

  1. 1Go to Ro's Foundayo page and complete the online health assessment (~5 minutes)
  2. 2A licensed Ro provider reviews your information and determines if Foundayo is clinically appropriate
  3. 3Ro checks your insurance — if you're covered, they handle prior authorization. If not, they present cash-pay pricing.
  4. 4Medication ships to your door. Cash-pay patients can often receive medication within a week.
  5. 5Ongoing care — regular provider check-ins and 24/7 messaging access to your care team
Get started with Foundayo on Ro — check eligibility in 5 minutes →

If you already have a prescription: LillyDirect

Ask your doctor to send the prescription to LillyDirect Pharmacy (NPI: 1912889320). Lilly handles fulfillment with free home delivery or retail pharmacy pickup. No membership fee. Savings card applied automatically if eligible.

See LillyDirect self-pay pricing →

What to avoid

Foundayo is brand new, which means the window for scams is wide open. Do not purchase “orforglipron” from any unlicensed online pharmacy, discount drug site, or international seller. There is no generic version of Foundayo — if someone is selling cheap “orforglipron tablets,” it is not the real product. Stick to Ro, LillyDirect, Weight Watchers Med+, GoodRx Care, Amazon Pharmacy, or a verified retail pharmacy with a valid prescription.

Is Foundayo Covered by Insurance?

Some commercial insurance plans cover Foundayo, and with the free Foundayo Savings Card, eligible patients with commercial coverage may pay as low as $25 per month. Governmental beneficiaries are excluded from the savings card by federal law. For Medicare Part D beneficiaries, Eli Lilly has stated that eligible patients may be able to access Foundayo for approximately $50 per month beginning as soon as July 1, 2026.

The reality for most people right now

Foundayo is less than two weeks old. Most insurance formularies have not added it yet, and prior authorization will likely be required. If your plan does not cover it initially: 1) Appeal — prior authorization appeals succeed when supported with BMI history, weight-related comorbidities, and prior lifestyle interventions. Ask your prescriber to submit a letter of medical necessity. 2) Start self-pay while you wait — at $149/month for the starting dose, Foundayo's entry price is substantially lower than injectable GLP-1 alternatives. Starting self-pay does not prevent switching to insurance later. Ro's insurance concierge handles the prior authorization process on your behalf.
Check your Foundayo insurance coverage on Ro →

What Makes Foundayo Different From Every Other GLP-1

Foundayo (orforglipron) is a small-molecule, non-peptide GLP-1 receptor agonist — and those technical details matter for your experience as a patient.

Every other GLP-1 medication on the market (Ozempic, Wegovy, Mounjaro, Zepbound) is a peptide — a large, complex protein-like molecule. Peptides are fragile. They break down in your stomach, which is why most require injection. Oral Wegovy gets around this with a special formulation and strict fasting requirements to protect the peptide during absorption.

Why the “small molecule” structure changes everything:

  • Inherently stable in the GI tract — absorbs efficiently regardless of food or water intake. No fasting workarounds needed.
  • Take it any time — morning coffee, lunch, before bed, mid-travel. No timing requirement.
  • Room-temperature storage — no refrigeration needed (protect from light). TSA-friendly for travelers.
  • Manufacturing advantage — small-molecule drugs are generally cheaper and faster to manufacture at scale than peptide biologics. This may influence long-term pricing accessibility, though we cannot predict Lilly's future pricing decisions.

Ready to Check If Foundayo Is Right for You?

A licensed Ro provider reviews your health profile, checks your insurance, and handles everything — from assessment to your door. The online assessment takes about 5 minutes and there is no commitment to start.

Check Foundayo eligibility on Ro →Already have an Rx? LillyDirect →

Frequently Asked Questions About Foundayo

Yes. Foundayo (orforglipron) received FDA approval on April 1, 2026, making it the first non-peptide, small-molecule GLP-1 receptor agonist approved for chronic weight management. It is manufactured by Eli Lilly and is available by prescription only.

Foundayo medication costs $149/month for the 0.8 mg starting dose, $199/month for the 2.5 mg dose, and $299/month for the 5.5 mg through 17.2 mg doses (under Lilly's Self-Pay Journey Program, which reverts to $349 if a refill is missed past 45 days). Your 90-day medication total during the standard titration is $647 — before any platform or membership fees.

LillyDirect has a lower 90-day total of $647 (medication only, no platform fee) versus approximately $984 through Ro on a month-to-month membership. However, LillyDirect does not include a prescriber — you must have or find a doctor separately. Ro's membership covers clinician access, insurance concierge, and ongoing care. If you prepay Ro's annual plan, the membership drops to as low as $74/month.

The most common side effects are gastrointestinal: nausea, constipation, diarrhea, vomiting, abdominal pain, heartburn, gas, bloating, and indigestion. These are typically worst during dose titration (the first 2–3 months) and improve over time. Foundayo can be taken with food, which may help. Hair loss and headache are also reported. Serious but rare risks include pancreatitis, gallbladder problems, and kidney injury from dehydration.

Yes. Foundayo may reduce the effectiveness of oral contraceptives. The prescribing information recommends switching to a non-oral contraceptive method or adding a barrier method for 30 days after starting Foundayo and for 30 days after each dose increase. Since the standard titration involves multiple dose increases over the first several months, plan for alternative contraception throughout the entire titration period.

Yes. Do not exceed simvastatin 20 mg once daily while taking Foundayo, due to a CYP3A4 enzyme interaction. That is a specific label instruction, not a vague warning. If you are currently on a higher simvastatin dose, your prescriber will need to adjust it or switch you to a different statin before starting Foundayo.

No. Concomitant use with another GLP-1 receptor agonist is not recommended. If switching from another GLP-1 to Foundayo, work with your provider on transition timing.

Through Ro (online assessment, licensed provider visit, prescription, insurance check, and home delivery — start for $39), LillyDirect (if you already have a prescription — no platform fee), Weight Watchers Med+, GoodRx Care, or Amazon Pharmacy. A valid prescription is required through all channels.

The standard titration starts at 0.8 mg and increases monthly: 2.5 mg in month 2, 5.5 mg in month 3, with potential increases to 9 mg, 14.5 mg, or 17.2 mg based on response and tolerability. Reaching the maximum dose of 17.2 mg typically takes 5–6 months.

No. Foundayo has been available to patients since April 6–9, 2026. Long-term real-world reviews do not yet exist. Credible reviews at this stage are based on clinical trial data from over 4,500 participants in the ATTAIN-1 and ATTAIN-2 trials, verified pricing across access routes, clinician commentary, and early community reactions. We will update this page monthly as real-world data accumulates.

Foundayo is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN 2), or known serious hypersensitivity to orforglipron. It is also not recommended for people with severe gastroparesis, during pregnancy or breastfeeding, or in combination with another GLP-1 receptor agonist.

Still Not Sure Which GLP-1 Program Is Right for You?

Take our free 60-second matching quiz. We'll ask a few quick questions about your insurance, budget, needle comfort, and health goals — then give you a personalized recommendation with the specific next step to take.

Take the free 60-second quiz →

Related GLP-1 Guides

Sources & References

  1. 1. FDA Approval Announcement — Foundayo (orforglipron), April 1, 2026
  2. 2. Eli Lilly Investor Relations — FDA Approves Foundayo, April 1, 2026
  3. 3. Foundayo Prescribing Information (PI)
  4. 4. LillyDirect Foundayo Pricing Page
  5. 5. Ro Foundayo Page and Pricing
  6. 6. Foundayo Coverage and Savings — Lilly
  7. 7. ATTAIN-1 Trial (NCT05869903) — ClinicalTrials.gov
  8. 8. Reuters — Americans Want Weight-Loss Pills for Cost, Convenience, April 2026
  9. 9. Managed Healthcare Executive — Foundayo vs. Oral Wegovy: Similarities, Differences, and What You Need to Know
  10. 10. Business Insider — What It's Like to Take Foundayo, April 2026

Last verified: April 11, 2026 · Last updated: April 11, 2026 · Weight Loss Provider Guide updates this page monthly as real-world Foundayo data accumulates.

All medical information is for educational purposes only and is not a substitute for professional medical advice. Consult a licensed healthcare provider before starting any medication.